Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 138

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 138
---
40): Disaggregation
of Income Statement Expenses (“ASU 2024-03”), which applies to all public business entities that file financial statements
with the SEC. The amendments in this ASU require public business entities to disclose on an annual and interim basis, disaggregated information
about certain income statement expense line items. The new standard is effective for fiscal years beginning after December 15, 2026,
with early adoption permitted. The Company is currently evaluating the impact that ASU 2024-03 will have on its financial statement disclosures.

F-18

3. INVENTORY

Inventory consists of the following major classes:

    December 31,  2024  
    December 31,  2023 
  
    Work in Process 
    $284,883  
    $278,987 
  
    Finished Goods 
     157,881  
     187,182 
  
    Inventory 
    $442,764  
    $466,169 

4. PROPERTY AND EQUIPMENT

As of December 31, 2024 and 2023, Property and Equipment, net consists
of:

    December 31,  
    December 31, 

    2024  
    2023 
  
    Lab Equipment 
    $233,411  
    $132,911 
  
    Machinery 
     55,800  
     55,800 
  
    Computer Equipment 
     7,000  
     14,084 
  
    Furniture 
     3,030  
     3,030 
  
    Property and Equipment, at cost 
     299,241  
     205,825 
  
    Accumulated Depreciation 
     (149,433) 
     (148,064)
  
    Property and Equipment, Net 
    $149,808  
    $57,761 

Machinery of $55,800 has not yet been placed
into service and therefore depreciation has not commenced as of December 31, 2024. Depreciation expenses for the years ended December
31, 2024 and 2023 were in the amount of $11,726 and $21,162, respectively.

5. INTANGIBLE ASSETS

As of December 31, 2024 and 2023, Intangible
Assets, net consist of:

    December 31, 2024  
    December 31,